- Home
- QSI vs RCEL Comparison
QSI vs RCEL Comparison
Compare QSI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- RCEL
- Stock Information
- Founded
- QSI 2013
- RCEL N/A
- Country
- QSI United States
- RCEL United States
- Employees
- QSI N/A
- RCEL N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- RCEL Medical/Dental Instruments
- Sector
- QSI Health Care
- RCEL Health Care
- Exchange
- QSI Nasdaq
- RCEL Nasdaq
- Market Cap
- QSI 219.8M
- RCEL 170.8M
- IPO Year
- QSI N/A
- RCEL N/A
- Fundamental
- Price
- QSI $1.68
- RCEL $5.62
- Analyst Decision
- QSI Strong Buy
- RCEL Strong Buy
- Analyst Count
- QSI 3
- RCEL 4
- Target Price
- QSI $2.38
- RCEL $17.25
- AVG Volume (30 Days)
- QSI 11.2M
- RCEL 347.9K
- Earning Date
- QSI 05-15-2025
- RCEL 05-08-2025
- Dividend Yield
- QSI N/A
- RCEL N/A
- EPS Growth
- QSI N/A
- RCEL N/A
- EPS
- QSI N/A
- RCEL N/A
- Revenue
- QSI $3,443,000.00
- RCEL $71,661,000.00
- Revenue This Year
- QSI $151.18
- RCEL $59.50
- Revenue Next Year
- QSI $172.07
- RCEL $28.89
- P/E Ratio
- QSI N/A
- RCEL N/A
- Revenue Growth
- QSI 167.94
- RCEL 41.35
- 52 Week Low
- QSI $0.61
- RCEL $5.46
- 52 Week High
- QSI $5.77
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- QSI 56.91
- RCEL 25.54
- Support Level
- QSI $1.45
- RCEL $6.06
- Resistance Level
- QSI $2.15
- RCEL $6.38
- Average True Range (ATR)
- QSI 0.20
- RCEL 0.47
- MACD
- QSI 0.02
- RCEL -0.11
- Stochastic Oscillator
- QSI 43.71
- RCEL 8.12
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.